This site is intended for healthcare professionals only
LoginRegister
Jemperli bags USFDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer: GSKJemperli bags USFDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer:...
Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in bloodThane: Spurious drugs worth Rs 1.85 crore seized, 2 booked
Biocon Biologics Yesafili gets Health Canada nod for eye diseasesApproval of Biocon Biologics Yesintek recommended by EMA Committee
Biocon Chief Kiran Mazumdar-Shaw conferred Jamsetji Tata Award by Indian Society for QualityBiocon Chief Kiran Mazumdar-Shaw conferred Jamsetji Tata Award by Indian Society for Quality
Intas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic DermatitisIntas Pharmaceutical gets CDSCO Panel nod to study Aflibercept Solution for Injection 40 mg/ml in...
Zydus Lifesciences Reports Rs 6,573.7 Cr Revenue in Q1 FY26, Net Profit Rises 3%Zydus Lifscience Gets CDSCO Panel Nod To study Anti-cancer Drug Pertuzumab
CDSCO Panel Clears AstraZenecas Datopotamab for Breast Cancer, Seeks Phase IV TrialCDSCO panel approves AstraZeneca's Protocol Amendment proposal for Anticancer Drug AZD5305 study
Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindnessRoche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness
Gilead Sciences gets USFDA nod for new Biktarvy indicationGilead Sciences Seladelpar gets positive CHMP opinion for Primary Biliary Cholangitis
Alembic buys UTI-focused Utility Therapeutics in USD 12 million dealAbbVie concludes acquisition of Aliada Therapeutics
Aurobindo Pharma arm CuraTeQ Biologics gets UK MHRA nod for cancer treatment BevqolvaAurobindo Pharma Slapped With Rs 11 Crore GST Demand, Plans Appeal
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIAIndian Pharma Market Posts Robust 10.7% Growth in November, Foracort Tops Sales: IQVIA
X